Tina J Hieken

32PUBLICATIONS
120CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Oct 01, 2026
Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).

|Aug 31, 2026
Body mass index-associated gut microbial taxa and functional pathways in women with benign and malignant breast disease.

|Jul 16, 2026
Breast Cancer Follow-Up and Surveillance After Primary Treatment: ASCO Guideline Update.

|May 30, 2026
Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma: Results From the Prospective NeoACTIVATE Arm C (NCT03554083) Substudy.

|Jan 22, 2026
Biomarker analysis of circulating tumor DNA in clinical stage III melanoma patients treated with neoadjuvant immunotherapy combined with targeted therapy.

Ronen Stoff, David M Routman, Mariana Yalon

|Oct 21, 2025
Primary Merkel Cell Carcinoma of the Deep Breast Parenchyma.

Kaitlyn J Nielson, David J Cook, Tina J Hieken

Pageof 6

Frequent Collaborators

4 joint publications

James W Jakub

3 joint publications

Jane Yuet Ching Hui

3 joint publications

Matthew Stephen Block

2 joint publications

Lisa A Kottschade